Literature DB >> 23971459

Sonography-guided percutaneous liver biopsies in children.

Pradeep Govender1, Maureen M Jonas, Ahmad I Alomari, Horacio M Padua, Brian J Dillon, Mary F Landrigan-Ossar, Gulraiz Chaudry.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the safety and efficacy of sonography-guided percutaneous core needle liver biopsy in infants and children.
MATERIALS AND METHODS: We conducted a retrospective analysis of all patients who underwent sonography-guided percutaneous core needle liver biopsies over a 7.5-year period by pediatric interventionalists at a single tertiary center.
RESULTS: A total of 597 procedures were performed in 470 patients (270 male and 200 female), with a mean age of 10.5 years (age range, 1 month-21 years). The main indications for biopsies were abnormal liver enzymes (n=129, 21.6%), grading and staging of chronic hepatitis B or C (n=105, 17.6%), evaluation of transplanted liver (n=111, 18.6%), iron overload (n=73, 12.2%), miscellaneous other diffuse parenchymal abnormalities (n=124, 20.7%), and focal hepatic lesions (n=55, 9.2%). The procedures were performed either under sedation (n=311, 52.1%) or general anesthesia (n=286, 47.9%). Diagnostic yield was obtained in 596 biopsies (99.8%) from an average of 2.4 cores in patients with diffuse disease (n=541, 90.6%) and 6.5 cores in patients with focal disease (n=55, 9.2%). Ten patients (1.7%) experienced a major complication, including pneumothorax (n=1, 0.2%), abdominal wall pseudoaneurysm (n=1, 0.2%), and symptomatic bleeding (n=8, 1.3%). Five of these children required transfusion, two were only admitted for observation, and one required surgical evacuation. There were no procedure-related deaths. Minor complications (n=49, 8.2%) included a symptomatic subcapsular hematoma (n=35) and stable small hemoperitoneum (n=9).
CONCLUSION: Sonography-guided percutaneous core liver biopsy is a safe and effective procedure in children that has a high diagnostic yield and very low complication rate.

Entities:  

Mesh:

Year:  2013        PMID: 23971459     DOI: 10.2214/AJR.12.9802

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Percutaneous liver biopsy in Fontan patients.

Authors:  Abhay Srinivasan; Anthony K Guzman; Elizabeth B Rand; Jack Rychik; David J Goldberg; Pierre A Russo; Anne Marie Cahill
Journal:  Pediatr Radiol       Date:  2018-11-30

2.  Practical approach for the diagnosis of biliary atresia on imaging, part 2: magnetic resonance cholecystopancreatography, hepatobiliary scintigraphy, percutaneous cholecysto-cholangiography, endoscopic retrograde cholangiopancreatography, percutaneous liver biopsy, risk scores and decisional flowchart.

Authors:  Marcello Napolitano; Stéphanie Franchi-Abella; Beatrice Maria Damasio; Thomas Angell Augdal; Fred Efraim Avni; Costanza Bruno; Kassa Darge; Damjana Ključevšek; Annemieke Simone Littooij; Luisa Lobo; Hans-Joachim Mentzel; Michael Riccabona; Samuel Stafrace; Seema Toso; Magdalena Maria Woźniak; Giovanni Di Leo; Francesco Sardanelli; Lil-Sofie Ording Müller; Philippe Petit
Journal:  Pediatr Radiol       Date:  2021-05-11

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

4.  Ultrasound shear wave speed measurements correlate with liver fibrosis in children.

Authors:  Jonathan R Dillman; Amer Heider; Jacob L Bilhartz; Ethan A Smith; Nahid Keshavarzi; Jonathan M Rubin; M James Lopez
Journal:  Pediatr Radiol       Date:  2015-04-08

5.  Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.

Authors:  Emily R Perito; Mercedes Martinez; Yumirle P Turmelle; Kristen Mason; Katharine M Spain; John C Bucuvalas; Sandy Feng
Journal:  Am J Transplant       Date:  2019-02-04       Impact factor: 8.086

6.  Predictors of diagnostic success in image-guided pediatric soft-tissue biopsies.

Authors:  Michael Acord; Raja Shaikh
Journal:  Pediatr Radiol       Date:  2015-05-10

7.  Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt.

Authors:  Gian Luigi Natali; Giulia Cassanelli; Guglielmo Paolantonio; George Koshy Parapatt; Lorenzo Maria Gregori; Massimo Rollo
Journal:  Pediatr Radiol       Date:  2022-09-19

8.  Evaluation of Percutaneous Liver Biopsy Complications in Patients with Chronic Viral Hepatitis.

Authors:  Sukran Kose; Gursel Ersan; Bengu Tatar; Pelin Adar; Buket Erturk Sengel
Journal:  Eurasian J Med       Date:  2015-10

Review 9.  Pediatric Non-Alcoholic Fatty Liver Disease.

Authors:  Edgard Delvin; Natasha Patey; Josée Dubois; Melanie Henderson; Émile Lévy
Journal:  J Med Biochem       Date:  2014-10-08       Impact factor: 3.402

10.  Same-Day versus Overnight Observation after Outpatient Pediatric Percutaneous Liver Biopsy: A Retrospective Cohort Study.

Authors:  Svetlana Yuryevna Kozlovich; Anthony Alexander Sochet; Sorany Son; Michael John Wilsey
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2019-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.